D
Anavex Life Sciences Corp. AVXL
$8.67 -$0.11-1.25% NASDAQ
Recommendation
Prev Close
$8.78
Volume
1,215,662
Avg Vol (90D)
1,015,594
Market Cap
$754.15M
Dividend & Yield
--
52-Week Range
$5.03 - $14.44
P/E (TTM)
--
EPS (TTM)
-$0.5665
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Noteworthy Thursday Option Activity: IMMR, AVXL, SKYT
9/18/2025 - Stock Options Channel
Anavex Life Sciences (AVXL, $8.96) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 16, 2025
9/17/2025 - Tickeron - Stocks
Anavex Life Sciences (AVXL, $9.09) entered Downtrend as Momentum indicator drops below 0 level on Sep 15, 2025
9/16/2025 - Tickeron - Stocks
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright
9/13/2025 - Ticker Report
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 4.8% - Here's What Happened
9/12/2025 - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright
9/12/2025 - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL)
9/12/2025 - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9% - Here's What Happened
9/11/2025 - MarketBeat
Anavex Life Sciences (AVXL, $8.88) price may climb as it broke lower Bollinger Band on Sep 10, 2025
9/11/2025 - Tickeron - Stocks
Anavex Life Sciences (AVXL, $8.88) entered Downtrend as Momentum indicator drops below 0 level on Sep 10, 2025
9/11/2025 - Tickeron - Stocks
Notable Wednesday Option Activity: CLSK, BKD, AVXL
9/10/2025 - Stock Options Channel
Anavex Life Sciences (AVXL, $10.26) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 9, 2025
9/10/2025 - Tickeron - Technical Analysis
Anavex Life Sciences (AVXL, $10.26) price may drop as it broke higher Bollinger Band on Sep 09, 2025
9/10/2025 - Tickeron - Technical Analysis
Anavex Life Sciences Stock Rises After Experimental Alzheimer's Drug Slows Cognitive Decline In Study
9/9/2025 - Stocktwits News Feed
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating ...
9/9/2025 - GuruFocus
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial
9/9/2025 - Globe Newswire
Anavex Life Sciences (AVXL, $9.36) entered Downtrend as Momentum indicator drops below 0 level on Sep 04, 2025
9/5/2025 - Tickeron - Stocks
Anavex Life Sciences (AVXL) Shares Cross Below 200 DMA
9/4/2025 - Market News Video
Anavex Life Sciences to Present at the H.C. ...
9/2/2025 - GuruFocus
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
9/2/2025 - GuruFocus
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
9/2/2025 - Globe Newswire
Anavex Life Sciences Corp. $AVXL Position Boosted by Wellington Management Group LLP
9/2/2025 - MarketBeat
Anavex Life Sciences Earnings Call: Promising Alzheimer's Progress Amid Operational Challenges
9/1/2025 - TipRanks Financial Blog
Anavex Life Sciences (AVXL, $9.64) RSI Indicator left the oversold zone on August 29, 2025
8/30/2025 - Tickeron - Stocks
Invesco Ltd. Sells 60,694 Shares of Anavex Life Sciences Corp. $AVXL
8/30/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$53.57M
Net Income (TTM)
-$48.17M
Balance Sheet
Total Assets (Q)
$102.43M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$11.47M
Book Value Per Share (Q)
$1.06
Cash Flow
Cash from Operations (TTM)
-$37.10M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
-$494.00K
Net Change in Cash (TTM)
-$37.59M
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Dec 22 and 26 (est)
Price History
Loading...
Beta
1.47
7-Day Total Return
-15.50%
30-Day Total Return
-20.97%
60-Day Total Return
-9.31%
90-Day Total Return
5.09%
Year to Date Total Return
-28.64%
1-Year Total Return
57.64%
2-Year Total Return
21.60%
3-Year Total Return
-4.52%
5-Year Total Return
104.00%
52-week Low
Oct 10, 2024 - $5.03
52-week High
Dec 26, 2024 - $14.44
Valuation
Market Cap
$754.15M - Small Cap
Enterprise Value
$652.98M
Price/Sales (TTM)
--
Price/Book (Q)
8.24
Dividends and Shares
Shares Outstanding
85.38
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.anavex.com
Phone Number
844 689 3939
Address
630 5th Avenue
New York, NY 10111
Country
United States
Year Founded
2004
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in the development of novel therapeutics for the treatment of neurodegenerative, neurodevelopmental, and... more
NASDAQ 09/18/2025 4:00PM Eastern Quotes delayed